Manzo Pharmaceuticals, Inc. (MNZO)

OTCMKTS · Delayed Price · Currency is USD
0.0001
+0.0001 (400.00%)
At close: Mar 9, 2026
9,900%
Market Cap 109.95K
Revenue (ttm) n/a
Net Income (ttm) 7.75M
Shares Out 1.10B
EPS (ttm) 1.91
PE Ratio 0.00
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 25,002
Average Volume 336,128
Open 0.0001
Previous Close 0.0000
Day's Range 0.0001 - 0.0001
52-Week Range n/a
Beta -52.76
RSI 56.48
Earnings Date n/a

About Manzo Pharmaceuticals

Manzo Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and testing of patented and non-patented solutions and remedies. The company is involved in developing Lacto-Freedom, a patented probiotic, which aids in the digestion of lactose containing foods primarily for people with lactose intolerance; and a natural remedy for colic in babies. It was formerly known as Fortune Oil & Gas, Inc. and changed its name to Manzo Pharmaceuticals, Inc. in September 2014. Manzo Pharmaceuticals, Inc. was incorporat... [Read more]

Industry Shell Companies
Sector Financials
Founded 1980
Employees 12
Stock Exchange OTCMKTS
Ticker Symbol MNZO
Full Company Profile

Financial Performance

In 2004, Manzo Pharmaceuticals's revenue was $3.07 million, an increase of 2.22% compared to the previous year's $3.00 million. Losses were -$4.15 million, 4.99% more than in 2003.

News

There is no news available yet.